Corvus Pharma sets IPO range at $15 to $17 a share

Corvus Pharmaceuticals said late Thursday it expects to price its initial public offering between $15 and $17 a share in a filing with the Securities and Exchange Commission. Corvus expect to offer 4.7 million shares, with about 705,000 additional shares to cover overallotments, in an IPO that could fetch up to $92 million. The company said it will trade on the Nasdaq under the ticker "CRVS".

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.